Sana Biotechnology
SANA
SANA
120 hedge funds and large institutions have $427M invested in Sana Biotechnology in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
16% less capital invested
Capital invested by funds: $507M → $427M (-$79.3M)
56% less call options, than puts
Call options by funds: $14K | Put options by funds: $32K
Holders
120
Holding in Top 10
2
Calls
$14K
Puts
$32K
Top Buyers
| 1 | +$6.91M | |
| 2 | +$6.54M | |
| 3 | +$2.41M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.12M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$932K |
Top Sellers
| 1 | -$4.01M | |
| 2 | -$3.58M | |
| 3 | -$2.91M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.03M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$650K |